Original language | English |
---|---|
Article number | 119 |
Journal | Signal Transduction and Targeted Therapy |
Volume | 8 |
Issue number | 1 |
DOIs | |
State | Published - 1 Dec 2023 |
ASJC Scopus subject areas
- Genetics
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Signal Transduction and Targeted Therapy, Vol. 8, No. 1, 119, 01.12.2023.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair
AU - Peng, Xin
AU - Wang, Yingying
AU - Zhang, Shaolu
AU - Tao, Zhennan
AU - Dai, Yuxiang
AU - Claret, Francois X.
AU - Elkabets, Moshe
AU - Lin, Hou Wen
AU - Chen, Zhe Sheng
AU - Kong, Dexin
N1 - Funding Information: This project was supported by grants from the National Natural Science Foundation of China (82073890, 81673464, and 82061148017, to DK; 22137006 and 82104054, to HW L), Fellowship of China Postdoctoral Science Foundation (2021M702464 to XP), Postgraduate Innovation Fund of 13th Five-Year comprehensive investment of Tianjin Medical University (YJSCX201806 to XP). SF295 cell line was kindly provided by the National Cancer Institute, National Institutes of Health, USA. We thank Dr. Xi Chen from Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Institute, Tianjin Eye Hospital for assistance in spectrometry proteomics data analysis. Funding Information: This project was supported by grants from the National Natural Science Foundation of China (82073890, 81673464, and 82061148017, to DK; 22137006 and 82104054, to HW L), Fellowship of China Postdoctoral Science Foundation (2021M702464 to XP), Postgraduate Innovation Fund of 13th Five-Year comprehensive investment of Tianjin Medical University (YJSCX201806 to XP). SF295 cell line was kindly provided by the National Cancer Institute, National Institutes of Health, USA. We thank Dr. Xi Chen from Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin Eye Institute, Tianjin Eye Hospital for assistance in spectrometry proteomics data analysis.
PY - 2023/12/1
Y1 - 2023/12/1
UR - http://www.scopus.com/inward/record.url?scp=85150667708&partnerID=8YFLogxK
U2 - 10.1038/s41392-023-01324-8
DO - 10.1038/s41392-023-01324-8
M3 - Letter
C2 - 36944633
AN - SCOPUS:85150667708
SN - 2095-9907
VL - 8
JO - Signal Transduction and Targeted Therapy
JF - Signal Transduction and Targeted Therapy
IS - 1
M1 - 119
ER -